共 36 条
[4]
Cimadamore Alessia, 2017, Critical Reviews in Oncogenesis, V22, P439, DOI 10.1615/CritRevOncog.2017020964
[6]
HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a -secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
[J].
INTERNATIONAL JOURNAL OF ONCOLOGY,
2018, 53 (01)
:99-112